Spiber, Inc. provides research, development, and production of synthetic spider silk. It specializes in the production of artificial spider silk using synthesized genes which persuade bacteria to produce fibroin, a structural protein found in spider silk. The firm analyzes the mechanism of the bimolecular structure of spider silk protein using bioinformatics. The company was founded on September 26, 2007 and is headquartered in Tsuruoka, Japan.
DBJ is an active, growth-oriented private equity investment manager investing across business development stages. In addition to investing capital, they promote the growth of their portfolio companies through the provision of support services including project conception, expansion planning and commercialization promotion. DBJ carries out economic, social and industrial research and seeks to identify local trends.Their investment strategies include seed capital, start-up incubation funds, early-stage loans secured by stock options, middle-stage loans for IP protection purposes and later stage loans. DBJ also invests in special situations such as revitalization, and have cooperated with the Tokyo-based automotive manufacturer Isuzu Motors Ltd. (TSE: 7202).
GOLDWIN INC. engages in the manufacture and sale of sporting goods. It also operates and manages golf courses and travel agency business. It carries the following product brands: GOLDWIN, C3fit, MXP, Speedo, ELLESSE, DANSKIN, CANTERBURY, BLACK & WHITE SPORT, and per se, The North Face, Helly Hansen, Macpac, Alite, Icebreaker, and others. The company was founded by Tosaku Nishida on December 22, 1951 and is headquartered in Oyabe, Japan.
The JAFCO Group defines their management philosophy as 'value creation through private equity' and aims to build an earnings base that can absorb changes in the business climate, encourage long-term profitability and support sustainable growth.The firm's full-line investment strategy covers venture capital investment in the seed and start-up, early, middle and later stages as well as buyout investment.They invest in high-growth sectors including IT-related, medical service, biotechnology and new services, in addition to industries such as manufacturing, distribution, retailing, and housing/finance. The majority of investments are in Japan, the remaining is equally divided between Asia ex-Japan and the US, with a small percentage in Europe.Part of the firm's investment strategy also includes actively participating in strengthening the corporate value in their investees' companies through post-investment value added activities.The firm utilizes flexible exit strategies to achieve optimal outcomes for their portfolio companies as well as their invested capital. While IPOs remain their primary method, they also use a variety of other approaches including cash sales and stock swaps.